Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Dr. Paul Janssen Award for Biomedical Research Issues 2017 Call for Nominations

PR Newswire January 10, 2017

Execs Giving CES Keynote Speeches Could Create Volatility For Shareholders

Benzinga.com  January 5, 2017

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2017

PR Newswire January 3, 2017

A Peek Into The Markets: U.S. Stock Futures Rise On Final Trading Day Of 2016

Benzinga.com  December 30, 2016

Wall Street's M&A Chatter From December 29

Benzinga.com  December 30, 2016

Johnson & Johnson to Participate in 35th Annual JP Morgan Health Care Conference

PR Newswire December 27, 2016

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter/Full-Year 2016 Results

PR Newswire December 27, 2016

20% return on Cisco Systems, or get option-trade ideas on Johnson & Johnson, Mondelez International, The Mosaic Company and Under Armour or any stock you choose

PR Newswire December 22, 2016

The Market In 5 Minutes: GDP, Jobless Claims And Micron

Benzinga.com  December 22, 2016

Wall Street's M&A Chatter From December 21

Benzinga.com  December 22, 2016

Johnson & Johnson Confirms Exclusive Negotiations with Actelion

PR Newswire December 21, 2016

Jefferies' 2017 Global Pharma Outlook

Benzinga.com  December 19, 2016

Research Reports on Drug Makers Equities -- Pfizer, Merck, AbbVie, and Johnson & Johnson

PR Newswire December 16, 2016

Watch These 7 Huge Call Purchases In Thursday Trade

Benzinga.com  December 15, 2016

Who Else Might Johnson & Johnson Seek To Acquire With Actelion Now Out Of Its Crosshairs?

Benzinga.com  December 14, 2016

Wall Street's M&A Chatter From December 13

Benzinga.com  December 14, 2016

Johnson & Johnson Announces it has Ended Discussions with Actelion

PR Newswire December 13, 2016

Fitbit, bluebird bio Inc., Johnson & Johnson, Skechers, and Diamond Offshore Drilling and more offer option-trading opportunities that offer returns of more than 20%

PR Newswire December 2, 2016

Dallas Jury Returns $1 Billion-Plus Verdict in Defective DePuy Hip Implants Lawsuit

PR Newswire December 1, 2016

Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion

Benzinga.com  November 29, 2016